The National Vaccine Injury Compensation Program ("Vaccine Program") comprises Part 2 of the National Childhood Vaccine Injury Act of 1986 ("Vaccine Act"). See Pub. L. No. 99-660, 100 Stat. 3755 (1986) (codified as amended at 42 U.S.C. §§ 300aa-1 to -34). The Vaccine Act became effective October 1, 1988. It establishes the Vaccine Program as a no-fault compensation program whereby petitions for monetary compensation may be brought by or on behalf of persons allegedly suffering injury or death as a result of the administration of certain compulsory childhood vaccines. Congress intended that the Vaccine Program provide individuals a swift, flexible, and less adversarial alternative to the often costly and lengthy civil arena of traditional tort litigation. Read more . . . [1]

Vaccine Rules of the United States Court of Federal Claims [2]

Vaccine Guidelines and Sample Filings [3]

Pro Se Information (Individuals Representing Themselves) [4]

OSM Attorneys' Forum Hourly Rate Fee Schedules [5]

Scam Targeting Vaccine Program Petitioners [6]

Notice of Vaccine Practices

• Chief Special Master's Statement on Special Processing Unit Claims [7]
• Office of Special Masters Pre-Assignment Review ("PAR") [8]
• Public Release of Rulings and Decisions [9]
• Exiting the Vaccine Program [10]
• Settlements and Alternative Dispute Resolution [11]
• Lost Wages and Federal Register Notices [12]
• Electronic Service on Secretary of Health and Human Services [13]
• OSM Attorneys' Fees and Costs Information [14]

Opinions/Orders [15]

Autism Proceeding [16]

Vaccine Attorneys [17]

The Office of Special Masters—an office within the United States Court of Federal Claims, see 42 U.S.C. § 300aa-12(c)—maintains a list of attorneys as a service to petitioners seeking compensation under the National Vaccine Program established by the Department of Health and Human Services. See 42 U.S.C. §§ 300aa-1, 12(a).

Please click here to view the Federal Judicial Center's video program on the Vaccine Injury Program and the U.S. Court of Federal Claims [18]